Panel: Delving into Clinical Trial Design to Accurately Assess GLP-1s in Comorbidities of Obesity
Time: 3:00 pm - 3:30 pm
day: Day One
Details:
- Exploring strategies for patient selection and stratification using baseline characteristics and specific comorbidities to assess differential treatment effects
- Considering the ethical implications of placebo arms to obtain reliable clinical data whilst ensuring patients receive required care
- Drawing on real world data to ensure adequate sample size and statistical testing to detect clinically meaningful differences
